To hear about similar clinical trials, please enter your email below
Trial Title:
Assessing Clinical Trial Experiences of Patients With Osteosarcoma
NCT ID:
NCT05535283
Condition:
Osteosarcoma
Conditions: Official terms:
Osteosarcoma
Conditions: Keywords:
osteosarcoma
Study type:
Observational
Overall status:
Not yet recruiting
Study design:
Time perspective:
Prospective
Summary:
Clinical study participation has historically been heavily biased toward specific
demographics.
Several people will be invited to enroll in this study so that it may collect a variety
of data about osteosarcoma clinical trial experiences and identify barriers to
participation as well as the causes of participants' failure or withdrawal.
People with osteosarcoma who are invited to take part in medical research will benefit
from the analysis of the data.
Criteria for eligibility:
Study pop:
Osteosarcoma patients who are actively considering enrolling in an interventional
clinical trial, but have not yet completed enrollment and randomization.
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
- Patient has been diagnosed with osteosarcoma
- Patient has self-identified as planning to enroll in an interventional clinical
trial
- Patient is a minimum of 18 years or older
Exclusion Criteria:
- ECOG score of 4
- Patient is pregnant
- Inability to perform regular electronic reporting
- Patient does not understand, sign, and return consent form
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Start date:
October 2024
Completion date:
October 2026
Lead sponsor:
Agency:
Power Life Sciences Inc.
Agency class:
Industry
Source:
Power Life Sciences Inc.
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05535283
